We are exploring next-generation therapies for people with eye diseases.
Marking nearly 15 years in Australia, Astellas is a world leader in the development of innovative new medicines, employing more than 17,500 people globally. With a strong foundation in Oncology, Urology, and Transplant, we are now broadening our horizons to include new therapeutic areas such as Ophthalmology.
By combining our expertise in eye biology with cutting-edge technologies, we’re pioneering new approaches including novel cell- and gene-based therapies.
We’re looking forward to meeting with the ophthalmic community and engaging in the latest scientific discussions, as we believe that together we can deliver meaningful value to patients who are urgently waiting.
local MSL
to learn more.
Alex Abalos
Natalie Buckman
QLD, WA, NT
NSW, ACT
MBBS B.Sc (med) Ophthalmology
t. 0439 605 923
t. 0401 192 393
Astellas Pharma Australia Pty Ltd. ABN 81 147 915 482. Suite 2.01, 2 Banfield Road, Macquarie Park, NSW 2113. All trademarks are the property of their respective owners. Date of preparation: April 2025. MAT-AU-NON-2025-00027. WED2423.
Michelle Waugh
VIC, SA, TAS
t. 0413 139 151